APTICEL

Serial Number 75319742
606

Registration Progress

Application Filed
Jul 7, 1997
Under Examination
Aug 4, 1998
Approved for Publication
Apr 10, 1998
Published for Opposition
May 12, 1998
Registered

Trademark Image

APTICEL

Basic Information

Serial Number
75319742
Filing Date
July 7, 1997
Published for Opposition
May 12, 1998
Abandonment Date
August 5, 2000
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 5, 2000
Classes
005

Rights Holder

GENETICS INSTITUTE, INC.

03
Address
85 CambridgePark Drive
Cambridge, MA 02140

Ownership History

GENETICS INSTITUTE, INC.

Original Applicant
03
Cambridge, MA

GENETICS INSTITUTE, INC.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
MARY MARON CHELI

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Oct 10, 2001 EX4D S SOU EXTENSION 4 DENIAL LETTER PREPARED Loading...
Oct 10, 2001 EX4M S SOU EXTENSION 4 DENIAL LETTER PREPARED Loading...
Aug 8, 2001 PETG O PETITION TO REVIVE-GRANTED Loading...
Jan 20, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 20, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 14, 2000 PETR I PETITION TO REVIVE-RECEIVED Loading...
Aug 4, 2000 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 2, 2000 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 2, 2000 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 2, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 2, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 22, 1998 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 5, 1998 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 4, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 12, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 10, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Feb 10, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
protein based pharmaceutical for treating disorders of the immune system or for stimulating the immune system
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005